• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

染色体微阵列分析在不明原因发育迟缓/智力障碍儿童中的应用。

Utility of Chromosomal Microarray in Children with Unexplained Developmental Delay/Intellectual Disability.

机构信息

Department of Cytogenetics, Christian Medical College and Hospital, Vellore, India.

Department of Neurological Sciences, Christian Medical College and Hospital, Vellore, India.

出版信息

Fetal Pediatr Pathol. 2022 Apr;41(2):208-218. doi: 10.1080/15513815.2020.1791292. Epub 2020 Jul 23.

DOI:10.1080/15513815.2020.1791292
PMID:32701375
Abstract

To evaluate the chromosomal microarray (CMA) yield among children who presented with global developmental delay/intellectual disability (GDD/ID) with/without co-occurring conditions. The pathogenic copy number variation (pCNVs) findings on CMA of all children who presented with unexplained GDD/ID were categorized based on the clinical features. The karyotype results were compared with CMA. The overall pCNV yield in children presenting with GDD/ID with or without comorbid conditions constituted 20.9%. Among the 17 pCNVs, 13 were losses and four were gains. Cardiac defect was the only co-morbidity in our study that demonstrated statistically significant prediction for pCNV (odds ratio 6.13, p value- 0.031). Six children who were karyotyped prior to CMA testing showed a structural abnormality. In our study, 20.9% of children with GDD/ID showed pCNVs on CMA. Cardiac defect alongside GDD/ID, emerged as the single strongest phenotype associated with pCNVs. CMA also provided vital information in previously karyotyped patients.

摘要

为了评估伴有/不伴有共病的全面发育迟缓/智力障碍(GDD/ID)患儿中染色体微阵列(CMA)的检出率。对所有表现为不明原因 GDD/ID 的患儿的 CMA 上致病性拷贝数变异(pCNVs)发现结果,基于临床特征进行分类。比较核型结果与 CMA。伴有或不伴有合并症的 GDD/ID 患儿的总体 pCNV 检出率为 20.9%。在 17 个 pCNVs 中,13 个是缺失,4 个是增益。在我们的研究中,心脏病是唯一具有统计学意义的 pCNV 预测共病(比值比 6.13,p 值为 0.031)。在 CMA 检测之前进行核型分析的 6 名患儿显示出结构异常。在我们的研究中,20.9%的 GDD/ID 患儿在 CMA 上显示出 pCNVs。心脏病与 GDD/ID 一起,是与 pCNVs 相关的唯一最强表型。CMA 还为之前核型分析过的患者提供了重要信息。

相似文献

1
Utility of Chromosomal Microarray in Children with Unexplained Developmental Delay/Intellectual Disability.染色体微阵列分析在不明原因发育迟缓/智力障碍儿童中的应用。
Fetal Pediatr Pathol. 2022 Apr;41(2):208-218. doi: 10.1080/15513815.2020.1791292. Epub 2020 Jul 23.
2
Application of chromosomal microarrays in the evaluation of intellectual disability/global developmental delay patients - A study from a tertiary care genetic centre in India.染色体微阵列在智力障碍/全面发育迟缓患者评估中的应用——来自印度一家三级医疗遗传中心的研究。
Gene. 2016 Sep 15;590(1):109-19. doi: 10.1016/j.gene.2016.06.020. Epub 2016 Jun 9.
3
Chromosomal microarray analysis in developmental delay and intellectual disability with comorbid conditions.发育迟缓与智力残疾合并症的染色体微阵列分析
BMC Med Genomics. 2018 May 24;11(1):49. doi: 10.1186/s12920-018-0368-4.
4
Confirmation of chromosomal microarray as a first-tier clinical diagnostic test for individuals with developmental delay, intellectual disability, autism spectrum disorders and dysmorphic features.证实染色体微阵列分析可作为发育迟缓、智力障碍、自闭症谱系障碍和发育异常特征的个体的一线临床诊断测试。
Eur J Paediatr Neurol. 2013 Nov;17(6):589-99. doi: 10.1016/j.ejpn.2013.04.010. Epub 2013 May 24.
5
Chromosomal Microarray With Clinical Diagnostic Utility in Children With Developmental Delay or Intellectual Disability.具有临床诊断效用的染色体微阵列分析在发育迟缓或智力障碍儿童中的应用。
Ann Lab Med. 2018 Sep;38(5):473-480. doi: 10.3343/alm.2018.38.5.473.
6
Cost Effectiveness of Karyotyping, Chromosomal Microarray Analysis, and Targeted Next-Generation Sequencing of Patients with Unexplained Global Developmental Delay or Intellectual Disability.对于不明原因的全面发育迟缓或智力残疾患者,核型分析、染色体微阵列分析和靶向下一代测序的成本效益。
Mol Diagn Ther. 2018 Feb;22(1):129-138. doi: 10.1007/s40291-017-0309-5.
7
Phenotypic Analysis of Korean Patients with Abnormal Chromosomal Microarray in Patients with Unexplained Developmental Delay/Intellectual Disability.韩国不明原因发育迟缓/智力残疾患者染色体微阵列异常的表型分析。
Yonsei Med J. 2018 May;59(3):431-437. doi: 10.3349/ymj.2018.59.3.431.
8
Chromosomal Aberrations in Pediatric Patients With Moderate/Severe Developmental Delay/Intellectual Disability With Abundant Phenotypic Heterogeneities: A Single-Center Study.染色体异常在具有丰富表型异质性的中重度发育迟缓/智力残疾的儿科患者中的表现:一项单中心研究。
Pediatr Neurol. 2023 Oct;147:72-81. doi: 10.1016/j.pediatrneurol.2023.06.001. Epub 2023 Jun 21.
9
Chromosomal Aberrations in Pediatric Patients with Developmental Delay/Intellectual Disability: A Single-Center Clinical Investigation.染色体异常与发育迟缓/智力障碍儿科患者:单中心临床研究。
Biomed Res Int. 2019 Nov 6;2019:9352581. doi: 10.1155/2019/9352581. eCollection 2019.
10
Diagnostic yield of patients with undiagnosed intellectual disability, global developmental delay and multiples congenital anomalies using karyotype, microarray analysis, whole exome sequencing from Central Brazil.巴西中部地区对不明原因智力障碍、全面发育迟缓伴多发先天畸形患者进行核型分析、微阵列分析和全外显子测序的诊断率
PLoS One. 2022 Apr 7;17(4):e0266493. doi: 10.1371/journal.pone.0266493. eCollection 2022.

引用本文的文献

1
Profiling the developmental signatures of genetic global developmental delay.剖析遗传性全球发育迟缓的发育特征。
Pediatr Res. 2025 Jul 9. doi: 10.1038/s41390-025-04268-7.
2
Uncovering genetic contributors to developmental delay and intellectual disability: a focus on CNVs in pediatric patients.揭示发育迟缓与智力残疾的遗传因素:聚焦儿科患者的拷贝数变异
Front Genet. 2025 Jun 23;16:1539902. doi: 10.3389/fgene.2025.1539902. eCollection 2025.
3
Trio-whole exome sequencing reveals the importance of de novo variants in children with intellectual disability and developmental delay.
三向全外显子组测序揭示了新生变异在智力残疾和发育迟缓儿童中的重要性。
Sci Rep. 2024 Nov 11;14(1):27590. doi: 10.1038/s41598-024-79431-x.
4
Comprehensive evaluation of the child with global developmental delays or intellectual disability.对患有全面发育迟缓或智力残疾儿童的综合评估。
Clin Exp Pediatr. 2024 Sep;67(9):435-446. doi: 10.3345/cep.2023.01697. Epub 2024 May 29.
5
Combining chromosomal microarray and clinical exome sequencing for genetic diagnosis of intellectual disability.采用染色体微阵列和临床外显子组测序联合进行智力障碍的遗传学诊断。
Sci Rep. 2023 Dec 20;13(1):22807. doi: 10.1038/s41598-023-50285-z.
6
Clinical and Genetic Characteristics of Patients with Unexplained Intellectual Disability/Developmental Delay without Epilepsy.无癫痫的不明原因智力残疾/发育迟缓患者的临床和遗传特征
Mol Syndromol. 2023 Jun;14(3):208-218. doi: 10.1159/000529018. Epub 2023 Mar 14.
7
Genome-Wide Sequencing Modalities for Children with Unexplained Global Developmental Delay and Intellectual Disabilities-A Narrative Review.不明原因的全面发育迟缓及智力障碍儿童的全基因组测序方式——一篇叙述性综述
Children (Basel). 2023 Mar 3;10(3):501. doi: 10.3390/children10030501.